Medicine and Dentistry
Nasopharynx Carcinoma
100%
Neoplasm
45%
Nasopharynx Cancer
45%
Epstein Barr Virus
32%
Virus DNA
26%
Malignant Neoplasm
22%
Radiation Therapy
22%
Chemoradiotherapy
21%
Disease
21%
Patient Referral
19%
Recurrent Disease
18%
Nasopharyngeal Angiofibroma
15%
Head and Neck Cancer
14%
Cancer
13%
Neck
12%
Systematic Review
12%
Epstein-Barr Virus
11%
Immunocompetent Cell
11%
Tumor Microenvironment
11%
Ossifying Fibroma
11%
COVID-19
11%
Biopsy
10%
Symptom
9%
Carcinoma
9%
Radical Surgery
8%
Epstein-Barr Virus Infection
8%
Recurrence Risk
8%
Secretion (Process)
8%
Plummer-Vinson Syndrome
8%
Biological Marker
7%
Infection
7%
Surgical Approach
7%
Cross Sectional Study
7%
Histopathology
6%
Overall Survival
6%
Physical Disease by Body Function
6%
Xerostomia
6%
Temoporfin
5%
Arm
5%
Nasoendoscopy
5%
Pediatrics
5%
Narrow Band Imaging
5%
Inverted Papilloma
5%
Photodynamic Therapy
5%
Incidence (Epidemiology)
5%
microRNA
5%
Delayed Diagnosis
5%
Programmed Death-Ligand 1
5%
DNA Methylation
5%
Oncoprotein
5%
Keyphrases
Nasopharyngeal Carcinoma
83%
Indonesia
52%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
50%
Nasopharyngeal Brushing
22%
Tumor
19%
Epstein-Barr Virus
17%
Epstein-Barr Virus DNA Load
17%
Jakarta
12%
Referral Hospital
12%
Postoperative Recurrence
11%
Tumor Microenvironment
11%
Juvenile Nasopharyngeal Angiofibroma
11%
Pada
11%
Ossifying Fibroma
11%
Nasopharyngeal
10%
Expression Level
10%
Cancer Patients
10%
Recurrence Rate
9%
Carcinoma
8%
Radical Surgery
8%
Conservative Surgery
8%
Plasma Epstein-Barr Virus DNA
8%
Epstein-Barr Virus Infections
8%
Indonesian
7%
Head-and-neck Cancer
7%
Overexpression
6%
BARF1
6%
Latent Membrane Protein 1 (LMP1)
6%
Type of Surgery
6%
Treatment Outcome
6%
Overall Survival
6%
Advanced Nasopharyngeal Carcinoma
6%
General Practitioners
6%
Early Signs
5%
EBNA1
5%
Head-and-neck
5%
Cancer Epidemiology
5%
MicroRNA
5%
Photodynamic Therapy
5%
Temoporfin
5%
Palliative Radiotherapy
5%
Radiotherapy Patients
5%
Single Institution Study
5%
Recurrent Nasopharyngeal Carcinoma
5%
Narrow Band Imaging
5%
Non-invasive Diagnosis
5%
Epstein-Barr
5%
Surgical Variables
5%
Tumor Origin
5%
Proviral DNA
5%